Daclizumab induction therapy in liver transplant recipients with renal insufficiency

BACKGROUND: The role of interleukin 2 (IL-2) receptor antibodies to avoid the nephrotoxic effects of calcineurin inhibitors in the early post-liver transplant (LT) period is not well defined. AIM: To examine the use of daclizumab induction in LT recipients with renal insufficiency. METHODS: Between...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Asrani, S. K., Kim, W. R., Pedersen, R. A., Charlton, M. R., Kremers, W. K., Therneau, T. M., Rosen, C. B., Dean, P. G.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3606263/
https://ncbi.nlm.nih.gov/pubmed/20659283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2036.2010.04408.x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki